The past, present, and future of telemedicine for Parkinson's disease

ABSTRACT Travel distance, growing disability, and uneven distribution of doctors limit access to care for most Parkinson's disease (PD) patients worldwide. Telemedicine, the use of telecommunications technology to deliver care at a distance, can help overcome these barriers. In this report, we...

Full description

Saved in:
Bibliographic Details
Published inMovement disorders Vol. 29; no. 7; pp. 871 - 883
Main Authors Achey, Meredith, Aldred, Jason L., Aljehani, Noha, Bloem, Bastiaan R., Biglan, Kevin M., Chan, Piu, Cubo, Esther, Ray Dorsey, E., Goetz, Christopher G., Guttman, Mark, Hassan, Anhar, Khandhar, Suketu M., Mari, Zoltan, Spindler, Meredith, Tanner, Caroline M., van den Haak, Pieter, Walker, Richard, Wilkinson, Jayne R.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.06.2014
Wiley Subscription Services, Inc
Subjects
Humans
Movement disorders
Nursing Care
Parkinson Disease - diagnosis
Parkinson Disease - therapy
Parkinson's disease
Patient Care
Remote Consultation
telemedicine
Telemedicine - trends
telemedicine
Parkinson's disease
Online AccessGet full text

Cover

More Information
Summary:ABSTRACT Travel distance, growing disability, and uneven distribution of doctors limit access to care for most Parkinson's disease (PD) patients worldwide. Telemedicine, the use of telecommunications technology to deliver care at a distance, can help overcome these barriers. In this report, we describe the past, present, and likely future applications of telemedicine to PD. Historically, telemedicine has relied on expensive equipment to connect single patients to a specialist in pilot programs in wealthy nations. As the cost of video conferencing has plummeted, these efforts have expanded in scale and scope, now reaching larger parts of the world and extending the focus from care to training of remote providers. Policy, especially limited reimbursement, currently hinders the growth and adoption of these new care models. As these policies change and technology advances and spreads, the following will likely develop: integrated care networks that connect patients to a wide range of providers; education programs that support patients and health care providers; and new research applications that include remote monitoring and remote visits. Together, these developments will enable more individuals with PD to connect to care, increase access to expertise for patients and providers, and allow more‐extensive, less‐expensive participation in research. © 2014 International Parkinson and Movement Disorder Society
Bibliography:ark:/67375/WNG-WL5W7XMG-B
ArticleID:MDS25903
istex:C4FEC68D0C9D747FB123C27118BCAB6A25AF540A
Full financial disclosures and author roles may be found in the online version of this article.
:
Dr. Biglan has telemedicine research‐related grants with the Davis Phinney Foundation, Great Lakes NeuroTechnologies, Michael J. Fox Foundation, and the Patient‐Centered Outcomes Research Institute and has filed a patent related to telemedicine and neurology. Dr. Dorsey has telemedicine research‐related grants with the Davis Phinney Foundation, Great Lakes NeuroTechnologies, Michael J. Fox Foundation, and the Patient‐Centered Outcomes Research Institute, is a member of the medical advisory board for, and has stock options in, Grand Rounds (an online second opinion service), is an unpaid advisor to SBR Health and Vidyo, and has filed a patent related to telemedicine and neurology. Dr. Goetz is an officer of the International Parkinson and Movement Disorder Society (MDS) that supports this program. Dr. Tanner is a coinvestigator on telemedicine research‐related grants with the Davis Phinney Foundation, the Patient‐Centered Outcomes Research Institute, and the MDS.
Relevant conflicts of interest/financial disclosures
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0885-3185
1531-8257
1531-8257
DOI:10.1002/mds.25903